At The Royal Marsden we offer state-of-the-art diagnostics and treatment for prostate cancer.
A full patient pathway is offered, from diagnosis to follow-up care with world-renowned prostate cancer experts dedicated to treating this cancer. The Royal Marsden employs leading edge diagnostic tests including; MRI, CT, endoscopy, ultrasound and image-guided biopsy. The Trust has also launched a new one-stop urological cancer Rapid Diagnostic and Assessment Centre in Chelsea.
We offer a range of treatment modalities from Active surveillance to surgical, chemotherapy and radiotherapy treatments depending on your diagnosis and stage of cancer. These include a robotic-assisted radical prostatectomy (removal of prostate) and salvage robotic prostatectomy for recurrent disease using the very latest in surgical robotic equipment, the da Vinci Xi system.
State-of-the-art radiotherapy, including image-guided radiotherapy, is used to offer patients a personalised treatment for their cancer, leading to fewer side effects and better outcomes. The Royal Marsden also uses CyberKnife to deliver stereotactic radiotherapy – a highly accurate method of targeting a tumour alongside offering low-dose brachytherapy, which is when tiny ‘seeds’ of radioactive iodine being implanted into the prostate gland, to treat patients with early prostate cancer.
We have a large portfolio of research studies, many led by clinicians at the Royal Marsden, and patients often have the chance to benefit from innovative approaches, used first in clinical trials.
For many patients, hormone therapy is the main form of treatment. It may be used on its own or in combination with other treatments such as radiotherapy and chemotherapy.
Thanks to supporters of The Royal Marsden Cancer Charity, we were the first NHS hospital in the country to introduce the da Vinci S surgical robot.
Your support helps us make a vital difference to the lives of cancer patients.